| Hepatitis C virus drug resistance–associated substitutions: State of the art summary E Lontok, P Harrington, A Howe, T Kieffer, J Lennerstrand, O Lenz, ... Hepatology 62 (5), 1623-1632, 2015 | 348 | 2015 |
| The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer BK Linderholm, T Lindahl, L Holmberg, S Klaar, J Lennerstrand, ... Cancer Research 61 (5), 2256-2260, 2001 | 261 | 2001 |
| Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro D Akaberi, J Krambrich, J Ling, C Luni, G Hedenstierna, JD Järhult, ... Redox biology 37, 101734, 2020 | 182 | 2020 |
| Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses A Luttens, H Gullberg, E Abdurakhmanov, DD Vo, D Akaberi, VO Talibov, ... Journal of the American Chemical Society 144 (7), 2905-2920, 2022 | 174 | 2022 |
| Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using … T Norberg, J Lennerstrand, M Inganäs, J Bergh International journal of cancer 79 (4), 376-383, 1998 | 93 | 1998 |
| Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds G Orozovic, K Orozovic, J Lennerstrand, B Olsen PloS one 6 (1), e16028, 2011 | 90 | 2011 |
| Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a N Palanisamy, A Danielsson, C Kokkula, H Yin, K Bondeson, L Wesslén, ... Antiviral research 99 (1), 12-17, 2013 | 77 | 2013 |
| Crystal structures of zidovudine-or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215 PP Chamberlain, J Ren, CE Nichols, L Douglas, J Lennerstrand, ... Journal of virology 76 (19), 10015-10019, 2002 | 76 | 2002 |
| Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate … PR Meyer, J Lennerstrand, SE Matsuura, BA Larder, WA Scott Journal of virology 77 (6), 3871-3877, 2003 | 73 | 2003 |
| Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine J Lennerstrand, DK Stammers, BA Larder Antimicrobial agents and chemotherapy 45 (7), 2144-2146, 2001 | 73 | 2001 |
| Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols A Borg, J Lennerstrand, M Stenmark-Askmalm, M Fernö, A Brisfors, ... British journal of cancer 71 (5), 1013-1017, 1995 | 72 | 1995 |
| Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards JD Järhult, S Muradrasoli, J Wahlgren, H Söderström, G Orozovic, ... PLoS One 6 (9), e24742, 2011 | 69 | 2011 |
| Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants J Lennerstrand, K Hertogs, DK Stammers, BA Larder Journal of virology 75 (15), 7202-7205, 2001 | 69 | 2001 |
| Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden I Lindström, M Kjellin, N Palanisamy, K Bondeson, L Wesslén, ... Infectious diseases 47 (8), 555-562, 2015 | 47 | 2015 |
| Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review SR Bartlett, J Grebely, AA Eltahla, JD Reeves, AYM Howe, V Miller, ... Hepatology communications 1 (5), 379-390, 2017 | 42 | 2017 |
| Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals AYM Howe, C Rodrigo, EB Cunningham, MW Douglas, J Dietz, J Grebely, ... JHEP Reports 4 (5), 100462, 2022 | 41 | 2022 |
| Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis HH de Witte, JA Foekens, J Lennerstrand, M Smid, MP Look, JGM Klijn, ... International journal of cancer 69 (2), 125-130, 1996 | 35 | 1996 |
| Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing XW Shao, A Malmsten, J Lennerstrand, A Sönnerborg, T Unge, ... Aids 17 (10), 1463-1471, 2003 | 24 | 2003 |
| Analysis of hepatitis C NS5A resistance associated polymorphisms using ultra deep single molecule real time (SMRT) sequencing A Bergfors, D Leenheer, A Bergqvist, A Ameur, J Lennerstrand Antiviral research 126, 81-89, 2016 | 23 | 2016 |
| Approaches for the development of antiviral compounds: the case of hepatitis C virus RF Schinazi, SJ Coats, LC Bassit, J Lennerstrand, JH Nettles, SJ Hurwitz Antiviral Strategies, 25-51, 2009 | 22 | 2009 |
